Uniphar Group PLC(UPR)
GBX --+0.00%
Reward52Moderate
Risk57Medium-High
📊75%Data
Thin 2% profit margin · Revenue growing 13% YoY
UPR
+0.0 · +0.00%
GBX · LSE
Uniphar Group PLC | Healthcare
Balanced
Market Cap:932.96M
ℹ️
Reward Rating
52
Moderate
Bottom 50% (model universe)
75% data coverage
ℹ️
Risk Rating
57
Medium-High
Risk Assessment
ℹ️

Educational tool only – Scores are based on historical data and financial metrics for informational purposes. This is not financial advice or a recommendation to buy or sell any security. Always conduct your own research or consult a qualified financial adviser.

ℹ️ Educational tool only · More
Limited data coverage
We don't have enough public data on UPR to score it reliably yet — Reward, Risk, Forecasts and Dividends tabs aren't available for this stock. The price chart and basic profile are still shown.
OTC / ADR stock — scores and fundamentals use data tagged in USD by our provider. The issuer may report in a different home currency (e.g. JPY), so treat figures as directional rather than precise.
Not available for limited-coverage stocks
The overview tab requires fundamentals and price history we don't have for this stock. The price chart is the most reliable view we have — try the Chart tab.

Market Performance

Stock returned +10.0% over the past year, broadly in line with market conditions.

Analyst Target

Analyst consensus price target: 376p.

What is Uniphar Group PLC?

Uniphar plc, together with its subsidiaries, operates as a diversified healthcare services company in the Republic of Ireland, the United Kingdom, the Netherlands, and internationally.

UPR · Verdict

Moderate reward · elevated risk

UPR has limited near-term tailwinds — balance sheet and profitability weigh on the model output.

Based on 88% data coverage

UPR · Verdict

What’s working & what to watch

Watchouts 2

  • Balance sheet28/100

    Interest covered 4.5×

  • Profitability43/100

    2% net margin · 13% ROE

Model-based scoring. For information only — not financial advice.

What is Uniphar Group PLC?

Uniphar plc, together with its subsidiaries, operates as a diversified healthcare services company in the Republic of Ireland, the United Kingdom, the Netherlands, and internationally. It operates through three divisions: Uniphar Medtech, Uniphar Pharma, and Uniphar Supply Chain & Retail. The company is listed on the LSE in UK, operating in the Healthcare sector, with a market capitalisation of 932.96M, and a P/E ratio of 20.6x.

Financial Highlights

Investment Breakdown

📈 Growth
Revenue and earnings growing steadily, indicating improving operating performance.
💰 Profitability
Profitability metrics are mixed — margins may be under pressure.
⚠️ Risk
Moderate volatility with meaningful macro and earnings sensitivity.
💸 Valuation
Valuation appears fair relative to current fundamentals.

OpenBook Logo Analysis

Reward: Moderate (52)

The scoring profile indicates limited reward potential at this time, with valuation and growth offering the most support. Risk indicators are elevated — volatility and macro sensitivity warrant consideration.

For informational purposes only. Not financial advice.

Company Information
SectorHealthcare
Market Cap932.96M
P/E Ratio20.5882
Dividend Yield0.56%
52 Week High368
52 Week Low204.6835
Last AnnualDecember
IPO DateN/A
IncorporatedUK
Shares Outstanding260M
No. of Employees3,500
IndustryMedical Distribution
ExchangeLSE
Beta1.193
CurrencyGBX · Reports in EUR